查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1538520

免疫调节剂市场报告：2030 年趋势、预测与竞争分析

Immunomodulator Market Report: Trends, Forecast and Competitive Analysis to 2030
出版日期: | 出版商: Lucintel | 英文 150 Pages | 商品交期: 3个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

免疫调节剂的趋势与预测

预计到 2030 年，全球免疫调节剂市场将达到 2.98 亿美元，2024 年至 2030 年复合年增长率为 4.6%。市场的主要驱动因素是多发性硬化症盛行率的增加、患者对高效药物的需求增加以及自体免疫疾病比例的增加。全球免疫调节剂市场的未来充满希望，呼吸系统、肿瘤和爱滋病市场存在机会。

免疫调节剂按细分市场

本研究按产品类型、应用和地区对全球免疫调节剂进行了预测。

免疫调节剂市场洞察

Lucintel 预测，由于免疫抑制剂可治疗许多自体免疫疾病，因此预计在预测期内将出现强劲增长。

在这个市场中，肿瘤学预计将在预测期内实现最高成长。

由于人口中慢性病的盛行率不断上升以及该地区主要企业的存在，北美在预测期内仍将是最大的地区。

常问问题

Q1.市场规模为：

A1. 到 2030 年，全球免疫调节剂市场预计将达到 2.98 亿美元。

Q2.市场成长预测是多少：

A2. 2024年至2030年，全球免疫调节剂市场预计将以4.6%的复合年增长率成长。

Q3.影响市场成长的主要驱动因素是：

A3. 此市场的主要驱动因素是多发性硬化症盛行率的增加、患者对高效药物的需求增加以及自体免疫疾病比例的增加。

Q4.市场的主要细分市场是：

A4. 免疫调节剂市场前景广阔，呼吸系统、肿瘤和爱滋病市场存在机会。

Q5.市场的主要企业是：

A5. 主要免疫调节剂公司如下：

  • F. Hoffmann-La Roche
  • Novartis
  • Biogen
  • Teva Pharmaceutical Industries
  • Amgen
  • Bristol-Myers & Squibb Company
  • Merck Sharp & Dohme

Q6.未来最大的细分市场是什么？

A6.Lucintel 预测，由于免疫抑制剂具有治疗自体免疫疾病的能力，预计在预测期内将出现高速增长。

Q7.未来五年预计哪些地区的市场成长最大？

A7. 由于人口中慢性病的盛行率不断上升以及该地区主要企业的存在，北美在预测期内仍将是最大的地区。

Q8. 可以客製化报告吗？

A8. 是的，Lucintel 提供 10% 的客製化服务，无需额外付费。

目录

第一章执行摘要

第二章全球免疫调节剂市场：市场动态

  • 简介、背景、分类
  • 供应链
  • 产业驱动因素与挑战

第三章 2018-2030年市场趋势及预测分析

  • 宏观经济趋势（2018-2023）与预测（2024-2030）
  • 全球免疫调节剂市场趋势（2018-2023）与预测（2024-2030）
  • 按产品类型分類的全球免疫调节剂市场
    • 免疫抑制剂
    • 免疫刺激剂
  • 全球免疫调节剂市场按应用
    • 呼吸系统
    • 瘤
    • HIV
    • 其他的

第四章 2018-2030年区域市场趋势及预测分析

  • 全球免疫调节剂市场区域分布
  • 北美免疫调节剂市场
  • 欧洲免疫调节剂市场
  • 亚太免疫调节剂市场
  • 其他地区免疫调节剂市场

第五章 竞争分析

  • 产品系列分析
  • 业务整合
  • 波特五力分析

第六章 成长机会与策略分析

  • 成长机会分析
  • 全球免疫调节剂市场的新趋势
  • 战略分析
    • 新产品开发
    • 全球免疫调节剂市场产能扩张
    • 全球免疫调节剂市场的併购和合资企业
    • 认证和许可

第七章主要企业概况

  • F. Hoffmann-La Roche
  • Novartis
  • Biogen
  • Teva Pharmaceutical Industries
  • Amgen
  • Bristol-Myers & Squibb Company
  • Merck Sharp & Dohme
简介目录

Immunomodulator Trends and Forecast

The future of the global immunomodulator market looks promising with opportunities in the respiratory, oncology, and HIV markets. The global immunomodulator market is expected to reach an estimated $298.0 million by 2030 with a CAGR of 4.6% from 2024 to 2030. The major drivers for this market are increasing multiple sclerosis incidence, rising patient need for efficient medications, and growing rates of autoimmune disorders.

A more than 150-page report is developed to help in your business decisions. Sample figures with some insights are shown below.

Immunomodulator by Segment

The study includes a forecast for the global immunomodulator by product type, application, and region.

Immunomodulator Market by Product Type [Shipment Analysis by Value from 2018 to 2030]:

  • Immunosuppressants
  • Immunostimulants

Immunomodulator Market by Application [Shipment Analysis by Value from 2018 to 2030]:

  • Respiratory
  • Oncology
  • HIV
  • Others

Immunomodulator Market by Region [Shipment Analysis by Value from 2018 to 2030]:

  • North America
  • Europe
  • Asia Pacific
  • The Rest of the World

List of Immunomodulator Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies immunomodulator companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the immunomodulator companies profiled in this report include-

  • F. Hoffmann-La Roche
  • Novartis
  • Biogen
  • Teva Pharmaceutical Industries
  • Amgen
  • Bristol-Myers & Squibb Company
  • Merck Sharp & Dohme

Immunomodulator Market Insights

Lucintel forecasts that immunosuppressant is expected to witness higher growth over the forecast period due to their ability to cure a number of autoimmune illnesses.

Within this market, oncology is expected to witness the highest growth over the forecast period.

North America will remain the largest region over the forecast period due to increasing prevalence of chronic diseases among population and presence of key players in the region.

Features of the Global Immunomodulator Market

Market Size Estimates: Immunomodulator market size estimation in terms of value ($M).

Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.

Segmentation Analysis: Immunomodulator market size by product type, application, and region in terms of value ($M).

Regional Analysis: Immunomodulator market breakdown by North America, Europe, Asia Pacific, and Rest of the World.

Growth Opportunities: Analysis of growth opportunities in different product types, applications, and regions for the immunomodulator market.

Strategic Analysis: This includes M&A, new product development, and competitive landscape of the immunomodulator market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

FAQ

Q1. What is the immunomodulator market size?

Answer: The global immunomodulator market is expected to reach an estimated $298.0 million by 2030.

Q2. What is the growth forecast for immunomodulator market?

Answer: The global immunomodulator market is expected to grow with a CAGR of 4.6% from 2024 to 2030.

Q3. What are the major drivers influencing the growth of the immunomodulator market?

Answer: The major drivers for this market are increasing multiple sclerosis incidence, rising patient need for efficient medications, and growing rates of autoimmune disorders.

Q4. What are the major segments for immunomodulator market?

Answer: The future of the immunomodulator market looks promising with opportunities in the respiratory, oncology, and HIV markets.

Q5. Who are the key immunomodulator market companies?

Answer: Some of the key immunomodulator companies are as follows:

  • F. Hoffmann-La Roche
  • Novartis
  • Biogen
  • Teva Pharmaceutical Industries
  • Amgen
  • Bristol-Myers & Squibb Company
  • Merck Sharp & Dohme

Q6. Which immunomodulator market segment will be the largest in future?

Answer: Lucintel forecasts that immunosuppressant is expected to witness higher growth over the forecast period due to their ability to cure a number of autoimmune illnesses.

Q7. In immunomodulator market, which region is expected to be the largest in next 5 years?

Answer: North America will remain the largest region over the forecast period due to increasing prevalence of chronic diseases among population and presence of key players in the region.

Q.8 Do we receive customization in this report?

Answer: Yes, Lucintel provides 10% customization without any additional cost.

This report answers following 11 key questions:

  • Q.1. What are some of the most promising, high-growth opportunities for the immunomodulator market by product type (immunosuppressants and immunostimulants), application (respiratory, oncology, HIV, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
  • Q.2. Which segments will grow at a faster pace and why?
  • Q.3. Which region will grow at a faster pace and why?
  • Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
  • Q.5. What are the business risks and competitive threats in this market?
  • Q.6. What are the emerging trends in this market and the reasons behind them?
  • Q.7. What are some of the changing demands of customers in the market?
  • Q.8. What are the new developments in the market? Which companies are leading these developments?
  • Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
  • Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
  • Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?

Table of Contents

1. Executive Summary

2. Global Immunomodulator Market : Market Dynamics

  • 2.1: Introduction, Background, and Classifications
  • 2.2: Supply Chain
  • 2.3: Industry Drivers and Challenges

3. Market Trends and Forecast Analysis from 2018 to 2030

  • 3.1. Macroeconomic Trends (2018-2023) and Forecast (2024-2030)
  • 3.2. Global Immunomodulator Market Trends (2018-2023) and Forecast (2024-2030)
  • 3.3: Global Immunomodulator Market by Product Type
    • 3.3.1: Immunosuppressants
    • 3.3.2: Immunostimulants
  • 3.4: Global Immunomodulator Market by Application
    • 3.4.1: Respiratory
    • 3.4.2: Oncology
    • 3.4.3: HIV
    • 3.4.4: Others

4. Market Trends and Forecast Analysis by Region from 2018 to 2030

  • 4.1: Global Immunomodulator Market by Region
  • 4.2: North American Immunomodulator Market
    • 4.2.1: North American Immunomodulator Market by Product Type: Immunosuppressants and Immunostimulants
    • 4.2.2: North American Immunomodulator Market by Application: Respiratory, Oncology, HIV, and Others
  • 4.3: European Immunomodulator Market
    • 4.3.1: European Immunomodulator Market by Product Type: Immunosuppressants and Immunostimulants
    • 4.3.2: European Immunomodulator Market by Application: Respiratory, Oncology, HIV, and Others
  • 4.4: APAC Immunomodulator Market
    • 4.4.1: APAC Immunomodulator Market by Product Type: Immunosuppressants and Immunostimulants
    • 4.4.2: APAC Immunomodulator Market by Application: Respiratory, Oncology, HIV, and Others
  • 4.5: ROW Immunomodulator Market
    • 4.5.1: ROW Immunomodulator Market by Product Type: Immunosuppressants and Immunostimulants
    • 4.5.2: ROW Immunomodulator Market by Application: Respiratory, Oncology, HIV, and Others

5. Competitor Analysis

  • 5.1: Product Portfolio Analysis
  • 5.2: Operational Integration
  • 5.3: Porter's Five Forces Analysis

6. Growth Opportunities and Strategic Analysis

  • 6.1: Growth Opportunity Analysis
    • 6.1.1: Growth Opportunities for the Global Immunomodulator Market by Product Type
    • 6.1.2: Growth Opportunities for the Global Immunomodulator Market by Application
    • 6.1.3: Growth Opportunities for the Global Immunomodulator Market by Region
  • 6.2: Emerging Trends in the Global Immunomodulator Market
  • 6.3: Strategic Analysis
    • 6.3.1: New Product Development
    • 6.3.2: Capacity Expansion of the Global Immunomodulator Market
    • 6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Immunomodulator Market
    • 6.3.4: Certification and Licensing

7. Company Profiles of Leading Players

  • 7.1: F. Hoffmann-La Roche
  • 7.2: Novartis
  • 7.3: Biogen
  • 7.4: Teva Pharmaceutical Industries
  • 7.5: Amgen
  • 7.6: Bristol-Myers & Squibb Company
  • 7.7: Merck Sharp & Dohme